Chemicals · Founded 1985 · www.chemplastsanmar.com · BSE 543336 · NSE CHEMPLASTS · ISIN INE488A01050
No Notes Added Yet
Business
Chemplast Sanmar Ltd. is a leading manufacturer of specialty chemicals and PVC resins in India. The company's core business model involves producing a diverse range of chemical products, including Specialty Paste PVC, Custom Manufactured Chemicals (for agrochemical and pharmaceutical sectors), Caustic Soda, and other PVC resins like Suspension PVC. It makes money by selling these products to a wide array of industrial customers in domestic and international markets.
Revenue Mix
Chemplast Sanmar primarily operates in two broad segments:
Specialty Chemicals: This segment includes Custom Manufactured Chemicals (CMC) for global agrochemical and pharmaceutical majors, and Specialty Paste PVC (or emulsion PVC) which is used in applications like synthetic leather, tarpaulins, and various industrial coatings. This segment is generally characterized by higher margins and long-term customer relationships.
PVC & Other Chemicals: This segment comprises Suspension PVC (used in pipes, fittings, cables, etc.), and Caustic Soda (a basic chemical used across numerous industries like alumina, pulp & paper, textiles). The company benefits from vertical integration in some of these operations.
Note: Specific percentage contributions can vary by fiscal year and are not consistently disclosed in concise overviews.
Industry
The company operates in the Indian chemicals sector, specifically within the PVC and specialty chemicals industries. The PVC market is largely driven by infrastructure and construction, while specialty chemicals cater to diverse industrial applications with higher value addition. Chemplast Sanmar is a market leader in India for Specialty Paste PVC and has a strong position in Custom Manufactured Chemicals, serving global clients. It also holds a significant position in Caustic Soda and Suspension PVC within the domestic market, leveraging its integrated facilities.
MOAT
Specialization & Niche Leadership: Market leadership in Specialty Paste PVC in India, a product requiring specific technical expertise and quality.
Custom Manufacturing Expertise: Deep process know-how, long-standing relationships with global agrochemical and pharmaceutical majors, and adherence to stringent quality standards, creating high switching costs for clients.
Vertical Integration: Backward integration into raw materials like caustic soda for PVC production provides cost advantages and supply chain stability.
Operational Scale & Technology: Significant manufacturing capacities and advanced technology for complex chemical processes.
Growth Drivers
"China Plus One" Strategy: Global companies diversifying their supply chains away from China are increasingly looking at Indian specialty chemical manufacturers.
Growing Demand for Specialty Chemicals: Increasing demand from end-user industries like agrochemicals, pharmaceuticals, and automotive, both domestically and internationally.
Domestic Infrastructure Growth: Drives demand for PVC in pipes, cables, and other construction-related applications.
Capacity Expansions: Planned and ongoing capacity enhancements in both specialty chemicals and PVC segments to meet anticipated demand.
New Product Development: Introduction of new custom-manufactured molecules for clients.
Risks
Commodity Price Volatility: Fluctuations in raw material prices (e.g., crude oil derivatives for PVC, energy for caustic soda) can impact profitability.
Cyclicality: PVC and Caustic Soda segments are susceptible to economic cycles and demand-supply imbalances.
Environmental Regulations: Stricter environmental norms and compliance costs could impact operations and capital expenditure.
Competition: Intense competition from both domestic and international players, especially in commodity chemicals.
Foreign Exchange Fluctuations: Given significant exports and imports, currency volatility can affect financial performance.
Management & Ownership
Chemplast Sanmar is part of the Sanmar Group, a well-established South Indian industrial conglomerate with a diversified business portfolio. The company is promoter-led, with the Sanmar Group holding a significant majority stake (typically over 50%), indicating strong promoter alignment. Management is generally perceived to have extensive experience in the chemical manufacturing sector.
Outlook
Chemplast Sanmar is well-positioned to capitalize on India's growth in specialty chemicals, driven by global supply chain diversification and increasing domestic demand from end-user industries like agrochemicals and pharmaceuticals. Its strong position in niche products and custom manufacturing provides a degree of insulation from commodity cycles. However, the company remains exposed to the inherent volatility of commodity prices for its PVC and Caustic Soda businesses, and global economic slowdowns could impact demand. Successful execution of capacity expansion plans and continued innovation in specialty chemicals will be key to sustainable long-term growth, while managing raw material and energy costs will be critical for profitability.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 888 | 1051 | 1145 | 993 | 1058 | 1151 | 1100 | 1033 | 835 | 1256 |
| Other Income | 13 | 13 | 12 | 11 | 11 | 14 | 9 | 7 | 5 | 7 |
| Total Income | 901 | 1063 | 1156 | 1004 | 1068 | 1165 | 1109 | 1040 | 841 | 1262 |
| Total Expenditure | 895 | 1030 | 1021 | 967 | 1026 | 1114 | 1083 | 990 | 892 | 1061 |
| Operating Profit | 6 | 34 | 136 | 37 | 43 | 51 | 26 | 50 | -51 | 201 |
| Interest | 47 | 51 | 59 | 57 | 59 | 62 | 59 | 60 | 58 | 58 |
| Depreciation | 38 | 46 | 45 | 45 | 47 | 62 | 53 | 52 | 53 | 55 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -150 |
| Profit Before Tax | -78 | -63 | 32 | -65 | -63 | -73 | -86 | -62 | -163 | -61 |
| Provision for Tax | 11 | -32 | 8 | -34 | -14 | -19 | -22 | -11 | -44 | -16 |
| Profit After Tax | -89 | -31 | 24 | -31 | -49 | -54 | -64 | -51 | -119 | -45 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -89 | -31 | 24 | -31 | -49 | -54 | -64 | -51 | -119 | -45 |
| Adjusted Earnings Per Share | -5.7 | -2 | 1.5 | -2 | -3.1 | -3.4 | -4.1 | -3.2 | -7.5 | -2.9 |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 3030 | 1254 | 1258 | 3799 | 5892 | 4941 | 3923 | 4346 | 4224 |
| Other Income | 27 | 12 | 8 | 16 | 57 | 80 | 80 | 47 | 28 |
| Total Income | 3057 | 1267 | 1266 | 3815 | 5949 | 5021 | 4003 | 4393 | 4252 |
| Total Expenditure | 2506 | 933 | 945 | 2837 | 4695 | 4473 | 3897 | 4127 | 4026 |
| Operating Profit | 551 | 333 | 320 | 978 | 1254 | 548 | 106 | 266 | 226 |
| Interest | 77 | 48 | 95 | 433 | 322 | 154 | 181 | 236 | 235 |
| Depreciation | 75 | 56 | 87 | 131 | 137 | 142 | 151 | 199 | 213 |
| Exceptional Income / Expenses | -13 | 0 | 0 | -16 | 0 | -81 | 0 | 0 | -150 |
| Profit Before Tax | 408 | 193 | 72 | 547 | 796 | 172 | -226 | -169 | -372 |
| Provision for Tax | 159 | 75 | 26 | 137 | 147 | 19 | -67 | -59 | -93 |
| Profit After Tax | 249 | 118 | 46 | 410 | 649 | 152 | -158 | -110 | -279 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 249 | 118 | 46 | 410 | 649 | 152 | -158 | -110 | -279 |
| Adjusted Earnings Per Share | 15.5 | 8.8 | 3.4 | 30.6 | 41 | 9.6 | -10 | -7 | -17.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 11% | -10% | 28% | 0% |
| Operating Profit CAGR | 151% | -40% | -4% | 0% |
| PAT CAGR | 0% | NAN% | NAN% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -54% | -25% | NA% | NA% |
| ROE Average | -83% | -23% | -14% | 0% |
| ROCE Average | 4% | 10% | 59% | 46% |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 545 | 1862 | 1913 | -384 | 1671 | 1824 | 1666 | 2034 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 170 | 677 | 1207 | 2059 | 833 | 964 | 1136 | 1137 |
| Other Non-Current Liabilities | 297 | 570 | 561 | 813 | 842 | 815 | 744 | 617 |
| Total Current Liabilities | 1614 | 692 | 428 | 1998 | 2256 | 2234 | 2484 | 2715 |
| Total Liabilities | 2626 | 3802 | 4108 | 4487 | 5602 | 5837 | 6030 | 6503 |
| Fixed Assets | 1016 | 2108 | 2174 | 3148 | 3259 | 3186 | 3907 | 4499 |
| Other Non-Current Assets | 110 | 158 | 1491 | 64 | 82 | 505 | 282 | 229 |
| Total Current Assets | 1500 | 1535 | 443 | 1255 | 2261 | 2146 | 1841 | 1775 |
| Total Assets | 2626 | 3802 | 4108 | 4487 | 5602 | 5837 | 6030 | 6503 |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 62 | 153 | 49 | 92 | 303 | 1000 | 1111 | 724 |
| Cash Flow from Operating Activities | 445 | 234 | 166 | 1076 | 901 | 355 | -245 | 172 |
| Cash Flow from Investing Activities | -370 | -311 | -438 | 2152 | 108 | -217 | -524 | -407 |
| Cash Flow from Financing Activities | 16 | -3 | 298 | -3017 | -313 | -27 | 382 | 66 |
| Net Cash Inflow / Outflow | 91 | -80 | 26 | 211 | 696 | 111 | -387 | -170 |
| Closing Cash & Cash Equivalent | 153 | 49 | 75 | 303 | 1000 | 1111 | 724 | 555 |
| # | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 15.53 | 8.84 | 3.44 | 30.59 | 41.02 | 9.64 | -10.02 | -6.98 |
| CEPS(Rs) | 20.24 | 13.04 | 9.96 | 40.36 | 49.7 | 18.62 | -0.45 | 5.6 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 34.07 | 57.73 | 63.1 | -141.69 | 4.52 | 16.97 | 9.84 | 7 |
| Core EBITDA Margin(%) | 16.41 | 25.47 | 24.71 | 25.31 | 20.31 | 9.47 | 0.66 | 5.03 |
| EBIT Margin(%) | 15.21 | 19.17 | 13.22 | 25.81 | 18.96 | 6.59 | -1.15 | 1.54 |
| Pre Tax Margin(%) | 12.79 | 15.34 | 5.67 | 14.4 | 13.5 | 3.47 | -5.75 | -3.89 |
| PAT Margin (%) | 7.79 | 9.4 | 3.65 | 10.8 | 11.01 | 3.08 | -4.04 | -2.54 |
| Cash Profit Margin (%) | 10.16 | 13.87 | 10.56 | 14.25 | 13.34 | 5.96 | -0.18 | 2.04 |
| ROA(%) | 9.46 | 3.69 | 1.17 | 9.54 | 12.86 | 2.66 | -2.67 | -1.76 |
| ROE(%) | 45.6 | 17.96 | 5.69 | 0 | 0 | 89.68 | -74.76 | -82.9 |
| ROCE(%) | 45.3 | 17.67 | 8.8 | 82.4 | 183.45 | 28.51 | -2.96 | 3.59 |
| Receivable days | 6.89 | 18.39 | 16.62 | 5.87 | 8.17 | 12.28 | 15.48 | 14.51 |
| Inventory Days | 35.83 | 74.32 | 55.18 | 28.29 | 34.63 | 50.02 | 56.37 | 51.48 |
| Payable days | 190.24 | 538.18 | 188.7 | 160.99 | 176.09 | 215.35 | 243.09 | 226.24 |
| PER(x) | 0 | 0 | 0 | 0 | 16.2 | 36.01 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 147.08 | 20.45 | 45.37 | 62.24 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.15 | 0.72 | 0.99 | 0.41 | 1.73 | 1.08 | 2 | 1.85 |
| EV/Core EBITDA(x) | 0.81 | 2.71 | 3.88 | 1.6 | 8.12 | 9.74 | 73.67 | 30.27 |
| Net Sales Growth(%) | 0 | -58.6 | 0.26 | 202.05 | 55.1 | -16.14 | -20.6 | 10.78 |
| EBIT Growth(%) | 0 | -50.16 | -30.83 | 486.47 | 34.42 | -70.86 | -113.84 | 248.3 |
| PAT Growth(%) | 0 | -52.34 | -61.06 | 789.07 | 148.7 | -76.51 | -203.99 | 30.34 |
| EPS Growth(%) | 0 | -43.12 | -61.06 | 789.07 | 34.13 | -76.51 | -203.99 | 30.34 |
| Debt/Equity(x) | 0.96 | 1.15 | 1.52 | -1.13 | 12.62 | 3.88 | 10.14 | 16.93 |
| Current Ratio(x) | 0.93 | 2.22 | 1.03 | 0.63 | 1 | 0.96 | 0.74 | 0.65 |
| Quick Ratio(x) | 0.74 | 1.93 | 0.61 | 0.42 | 0.69 | 0.67 | 0.51 | 0.41 |
| Interest Cover(x) | 6.28 | 5.01 | 1.75 | 2.26 | 3.47 | 2.11 | -0.25 | 0.28 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.09 | 0.19 | 0.22 | 0.27 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 |
| FII | 11.16 | 10.83 | 11.27 | 13.41 | 13.19 | 13.27 | 13.33 | 13.15 | 13.16 | 12.48 |
| DII | 27.51 | 28.15 | 28.39 | 25.74 | 25.82 | 25.81 | 25.65 | 25.62 | 25.52 | 25.62 |
| Public | 6.34 | 6.03 | 5.35 | 5.85 | 6 | 5.93 | 6.03 | 6.24 | 6.33 | 6.91 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 |
| FII | 1.76 | 1.71 | 1.78 | 2.12 | 2.09 | 2.1 | 2.11 | 2.08 | 2.08 | 1.97 |
| DII | 4.35 | 4.45 | 4.49 | 4.07 | 4.08 | 4.08 | 4.06 | 4.05 | 4.03 | 4.05 |
| Public | 1 | 0.95 | 0.85 | 0.93 | 0.95 | 0.94 | 0.95 | 0.99 | 1 | 1.09 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +11% | -10% | +28% | — |
| Operating Profit CAGR | +151% | -40% | -4% | — |
| PAT CAGR | — | 0% | 0% | — |
| Share Price CAGR | -54% | -25% | — | — |
| ROE Average | -83% | -23% | -14% | 0% |
| ROCE Average | +4% | +10% | +59% | +46% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 | 54.99 |
| FII | 11.16 | 10.83 | 11.27 | 13.41 | 13.19 | 13.27 | 13.33 | 13.15 | 13.16 | 12.48 |
| DII | 27.51 | 28.15 | 28.39 | 25.74 | 25.82 | 25.81 | 25.65 | 25.62 | 25.52 | 25.62 |
| Public | 45.01 | 45.01 | 45.01 | 45.01 | 45.01 | 45.01 | 45.01 | 45.01 | 45.01 | 45.01 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 | 8.69 |
| FII | 1.76 | 1.71 | 1.78 | 2.12 | 2.09 | 2.1 | 2.11 | 2.08 | 2.08 | 1.97 |
| DII | 4.35 | 4.45 | 4.49 | 4.07 | 4.08 | 4.08 | 4.06 | 4.05 | 4.03 | 4.05 |
| Public | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 | 15.81 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.